BioLargo, Inc. filed a Current Report on Form 8-K with the Securities and Exchange Commission on September 10, 2026, to disclose information presented during a webcast investor conference.
The registrant attached Exhibit 99.1, a slide deck presentation, to the filing. The company stated that the information contained in the exhibit and Item 7.01 of the report shall not be deemed "filed" for purposes of the Securities Exchange Act of 1934 and shall not be incorporated by reference into any future SEC filings.
The presentation was delivered on September 10, 2026, at 1:00 PM Pacific Time. The filing includes a cover page with interactive data embedded within the Inline XBRL document.
